Naproxen Export Market Intelligence: India's 192 Suppliers Shipping to 76 Countries — TransData Nexus 2026

Q: Who are the top naproxen exporters from India?

The top naproxen exporters from India are: 1. MYLAN LABORATORIES LIMITED — $23.3M (17.4% market share); 2. UNICHEM LABORATORIES LIMITED — $21.7M (16.2% market share); 3. GLENMARK PHARMACEUTICALS LIMITED — $14.1M (10.5% market share); 4. AMNEAL PHARMACEUTICALS PRIVATE LIMITED — $13.0M (9.7% market share); 5. GRANULES INDIA LIMITED — $8.5M (6.3% market share). Together they account for 60.2% of India's total naproxen export value.

Q: What is the total export value of naproxen from India?

The total export value of naproxen from India is $133.8M USD, recorded across 3,414 shipment transactions from 192 active exporters to 76 destination countries. The average shipment value is $39.2K.

Q: Which countries import naproxen from India?

India exports naproxen to 76 countries worldwide. The top importing countries are: UNITED STATES (42.1% share, $56.4M), CANADA (21.1% share, $28.3M), SLOVENIA (16.2% share, $21.7M), MALTA (6.5% share, $8.6M), SPAIN (4.5% share, $6.0M). These five markets account for 90.5% of total export value.

Q: What is the HS code for naproxen exports from India?

The primary HS code for naproxen exports from India is 30049069. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of naproxen exports from India?

The average unit price for naproxen exports from India is $15.88 USD per unit, with prices ranging from $0.01 to $1678.68 depending on formulation, packaging, and order volume. The total market is valued at $133.8M across 3,414 shipments.

Q: Which ports handle naproxen exports from India?

The primary ports for naproxen exports from India are NHAVA SHEVA SEA (INNSA1) (12.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.2% of shipments), SAHAR AIR (6.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.2% of shipments), JNPT/ NHAVA SHEVA SEA (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of naproxen?

India is one of the world's leading exporters of naproxen due to its large base of 192 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports naproxen to 76 countries, demonstrating 39% global market coverage.

Q: What certifications do Indian naproxen exporters need?

Indian naproxen exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import naproxen from India?

There are 366 registered buyers importing naproxen from India, spread across 76 countries. The repeat buyer rate is 65.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top naproxen supplier from India?

MYLAN LABORATORIES LIMITED is the leading naproxen exporter from India with a market share of 17.4% and total export value of $23.3M across 55 shipments. The top 5 suppliers together control 60.2% of total export value.

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Naproxen Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Naproxen to the World

Between 2022 and 2026, India exported $133.8M worth of naproxen across 3,414 verified shipments to 76 countries — covering 39% of world markets in the Analgesics & Antipyretics segment. The largest destination is UNITED STATES (42.1%). MYLAN LABORATORIES LIMITED leads with a 17.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Naproxen export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Naproxen export data snapshot — $133.8M · 192 exporters · 76 countriesTransData Nexus · Indian Customs Data

Top Naproxen Exporters from India

192 active exporters · Ranked by export value

View all 192 →

Top Naproxen Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$23.3M	55	3	17.4%
2	UNICHEM LABORATORIES LIMITED

Top Countries Importing Naproxen from India

76 destination markets · Ranked by import value

All 76 countries →

Top Countries Importing Naproxen from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$56.4M	42.1%
2	CANADA	$28.3M	21.1%
3	SLOVENIA	$21.7M	16.2%
4	MALTA	$8.6M	6.5%
5	SPAIN	$6.0M	4.5%
6	UNITED KINGDOM	$5.1M	3.8%
7	AUSTRALIA	$1.1M	0.8%
8	NETHERLANDS	$944.0K	0.7%
9	SWEDEN	$881.4K	0.7%
10	TURKMENISTAN	$674.5K	0.5%

UNITED STATES is India's largest naproxen export destination, absorbing 42.1% of total exports worth $56.4M. The top 5 importing countries — UNITED STATES, CANADA, SLOVENIA, MALTA, SPAIN — together account for 90.5% of India's total naproxen export value. The remaining 71 destination countries collectively receive the other 9.5%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Naproxen to India?

16 origin countries · Total import value: $789.9K

India imports naproxen from 16 countries with a combined import value of $789.9K. The largest supplier is UNITED STATES ($391.7K, 125 shipments), followed by GERMANY and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Naproxen to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$391.7K	125	49.6%
2	GERMANY	$185.0K	21	23.4%
3	CANADA	$173.7K	70	22.0%
4	PORTUGAL	$23.1K	6	2.9%
5	BRAZIL	$8.9K	3	1.1%
6	CHINA	$2.8K	3	0.4%
7	UNITED KINGDOM	$1.9K	5	0.2%
8	NETHERLANDS	$1.2K	5	0.2%
9	BULGARIA	$685	1	0.1%
10	ISRAEL	$324	2	0.0%

Showing top 10 of 16 origin countries

UNITED STATES is the largest supplier of naproxen to India, accounting for 49.6% of total import value. The top 5 origin countries — UNITED STATES, GERMANY, CANADA, PORTUGAL, BRAZIL — together supply 99.1% of India's naproxen imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Naproxen

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, naproxen is approved through multiple Abbreviated New Drug Applications (ANDAs). Notably, ANDA 74-936 for naproxen delayed-release tablets was approved on February 24, 1998, for Purepac Pharmaceutical Co. Subsequently, ANDA 75-390 received approval on April 19, 2001, for King and Spalding. Additionally, ANDA 207457 for sumatriptan and naproxen tablets (85 mg/500 mg) was approved for Aurobindo Pharma USA, Inc.

The regulatory pathway for naproxen in the U.S. involves demonstrating bioequivalence to the reference listed drug (RLD) through the ANDA process. Given the substantial number of Indian exporters (192) supplying naproxen to the U.S., compliance with FDA regulations, including Good Manufacturing Practices (GMP) and bioequivalence standards, is imperative to maintain market access.

2EU & UK Regulatory Framework

In the European Union, naproxen is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). The EMA conducts periodic safety update report single assessments (PSUSAs) for naproxen to ensure ongoing pharmacovigilance. For instance, procedure PSUSA/00002125/202308 resulted in a variation to the marketing authorization in June 2024. (ema.europa.eu)

Manufacturers exporting to the EU and UK must adhere to EU Good Manufacturing Practice (GMP) guidelines, which encompass quality management, personnel, premises, equipment, documentation, production, quality control, and self-inspection. Compliance with these standards is essential for obtaining and maintaining marketing authorizations within these jurisdictions.

3WHO Essential Medicines & Global Standards

Naproxen is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global healthcare. The drug is also subject to international pharmacopoeial standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards ensures the quality, safety, and efficacy of naproxen products in the global market.

4India Regulatory Classification

In India, naproxen is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, specific ceiling prices for naproxen are subject to periodic revisions. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for naproxen have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets. The absence of active patents allows for the production and export of generic naproxen without infringement concerns, promoting wider accessibility and affordability.

6Recent Industry Developments

In June 2024, the EMA concluded a periodic safety update report single assessment (PSUSA/00002125/202308) for naproxen, resulting in a variation to the marketing authorization to enhance safety information. (ema.europa.eu)

In March 2023, the EMA completed a PSUSA (PSUSA/00001270/202204) for the combination of esomeprazole and naproxen, leading to amendments in product information to reflect updated safety data. (ema.europa.eu)

These developments underscore the importance of continuous pharmacovigilance and regulatory compliance for naproxen manufacturers and exporters.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Naproxen

Retail & reference prices across 9 markets vs. India FOB export price of $15.88/unit

Global Price Benchmark for Naproxen across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.48	USD	According to the FDA, Naproxen is an approved nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.
United Kingdom	$0.50	GBP	The NHS Drug Tariff lists Naproxen as a prescription-only medication available through the National Health Service.
Germany	$0.44	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates the pricing and availability of Naproxen in Germany.
Australia	$0.45

Supply Chain Risk Assessment — Naproxen

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Naproxen, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of APIs and KSMs used in Indian pharmaceutical manufacturing are sourced from China. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade policy changes, and environmental regulations in China.

For instance, in 2024, stringent environmental regulations in China led to the shutdown of numerous chemical factories, causing a significant increase in the prices of KSMs and subsequent APIs. This event underscored the vulnerability of India's pharmaceutical supply chain to external factors affecting Chinese manufacturing.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Naproxen from India account for 60.2% of the total export value, with MYLAN LABORATORIES LIMITED alone contributing 17.4%. This high supplier concentration poses a risk, as any operational or compliance issues within these key companies could disrupt the supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic manufacturing of APIs and reduce import dependence. As of November 2024, two greenfield plants were inaugurated under this scheme to produce critical pharmaceutical ingredients, marking a significant step towards supply chain diversification.

Access Complete Naproxen Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,414 transactions across 76 markets.

Request Demo View Pricing

Frequently Asked Questions — Naproxen Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top naproxen exporters from India?

The leading naproxen exporters from India are MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 17.4% market share ($23.3M). The top 5 suppliers together control 60.2% of total export value.

What is the total export value of naproxen from India?

The total export value of naproxen from India is $133.8M, recorded across 3,414 shipments from 192 active exporters to 76 countries. The average shipment value is $39.2K.

Which countries import naproxen from India?

India exports naproxen to 76 countries. The top importing countries are UNITED STATES (42.1%), CANADA (21.1%), SLOVENIA (16.2%), MALTA (6.5%), SPAIN (4.5%), which together account for 90.5% of total export value.

What is the HS code for naproxen exports from India?

The primary HS code for naproxen exports from India is 30049069. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Naproxen

Naproxen

Top Naproxen Exporters from India

Top Countries Importing Naproxen from India

Who Supplies Naproxen to India?

Quick Facts

Related Analgesics & Antipyretics

Related Analysis

Need Details?

Regulatory Landscape — Naproxen

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Naproxen

Supply Chain Risk Assessment — Naproxen

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Naproxen Trade Intelligence

Frequently Asked Questions — Naproxen Exports from India

Who are the top naproxen exporters from India?

What is the total export value of naproxen from India?

Which countries import naproxen from India?

What is the HS code for naproxen exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of naproxen exports from India?

Which ports handle naproxen exports from India?

Why is India a leading exporter of naproxen?

What certifications do Indian naproxen exporters need?

How many buyers import naproxen from India?

What is the market share of the top naproxen exporter from India?

Analysis Methodology